GLP-1 receptor agonists for Parkinson's disease?

被引：0
|
作者：
不详
机构：
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2020年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] GLP-1 receptor agonists and the risk of colorectal cancer
    Kakkar, Ashish Kumar
    MEDICAL HYPOTHESES, 2014, 82 (06) : 796 - 796
  • [42] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [43] Appendicitis: A Hidden Danger of GLP-1 Receptor Agonists?
    Casella, Sarah
    Galli, Katelyn
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (02) : 108 - 111
  • [44] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Zhao, Xin
    Wang, Minghe
    Wen, Zhitong
    Lu, Zhihong
    Cui, Lijuan
    Fu, Chao
    Xue, Huan
    Liu, Yunfeng
    Zhang, Yi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [45] GLP-1 receptor agonists and heart failure in diabetes
    Scheen, Andre J.
    DIABETES & METABOLISM, 2017, 43 : 2S13 - 2S19
  • [46] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [47] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [48] Two New GLP-1 Receptor Agonists for Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 109 - 111
  • [49] Editorial: GLP-1 receptor agonists in inflammatory bowel disease-Is it time?
    Arvanitakis, Konstantinos
    Germanidis, Georgios
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (05) : 658 - 659
  • [50] Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
    Alhiary, Rasha
    Kesselheim, Aaron S.
    Gabriele, Sarah
    Beall, Reed F.
    Tu, S. Sean
    Feldman, William B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 650 - 657
12345